Glycation in Alzheimer’s Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions
<p dir="ltr">As global life expectancy increases, the prevalence of neurodegenerative diseases like Alzheimer’s disease (AD) continues to rise. Since therapeutic options are minimal, a deeper understanding of the pathophysiology is essential for improved diagnosis and treatments. AD...
محفوظ في:
| المؤلف الرئيسي: | Sama Ayoub (15430987) (author) |
|---|---|
| مؤلفون آخرون: | Maryam Arabi (3927509) (author), Yousef Al-Najjar (14147835) (author), Ibrahim Laswi (14787432) (author), Tiago F. Outeiro (191379) (author), Ali Chaari (827168) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer’s disease
حسب: Ahmad Raza (18205961)
منشور في: (2025) -
Protein Glycation in Plants—An Under-Researched Field with Much Still to Discover
حسب: Naila Rabbani (291722)
منشور في: (2020) -
AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
حسب: Naila Rabbani (291722)
منشور في: (2022) -
Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle
حسب: Jinit, Masania
منشور في: (2023) -
Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle
حسب: Jinit Masania (7164239)
منشور في: (2023)